FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34732311000001100: Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104988001000001112 Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109827701000001111 Fluoxetine 10mg tablets (Endo Ventures Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Is a Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has active ingredient Fluoxetine hydrochloride false Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has specific active ingredient Fluoxetine hydrochloride true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fluoxetine true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Has basis of strength substance Fluoxetine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has AMP True Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start